Biopharmaceutical mergers and acquisitions surge to new highs
In the first three months of 2024, the total deal value has reached a staggering $43.5 billion. GlobalData reports a remarkable 71% year-on-year increase in mega deals compared to last year It has been a roller coaster ride for the biopharmaceutical …